Western Health Advantage
Kisqali (600 MG Dose) (ribociclib)
Drugs for Cancer : Drugs for Cancer
  • 1;
  • PA Applies
  • PA Required
  • Solid Tumor with NTRK Gene Fusion:
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Specialty Pharmacy is Required: Not Defined